MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A comparative study of non-motor symptoms in Huntington’s disease and Parkinson’s disease

WZ. Hu, JH. Yin, LX. Cao, Y. Huang (Beijing, China)

Meeting: 2023 International Congress

Abstract Number: 1308

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features, Non-motor Scales, Parkinson’s

Category: Phenomenology and Clinical Assessment of Movement Disorders

Objective: To assess and compare the non-motor symptoms (NMS) profile in Parkinson’s disease (PD) and Huntington’s disease (HD) patients using Parkinson’s Disease Non-Motor Symptom Rating Scale (NMSS).

Background: NMS can be disabling and usually occur in HD and PD. The shared and distinct NMS features in HD and PD have not been fully understood.

Method: We have been conducting Tiantan longitudinal observational study for aging and neurodegenerative diseases (LOS-AND) since September 2018 with ethical approval from the Ethical Committee of Beijing Tiantan Hospital, Capital Medical University. By February 2023, 99 HD cases and 153 patients with PD have been consecutively recruited. The inclusion criteria for PD were that the patients met the clinical diagnostic criteria of the Movement Disorders Society (MDS); the inclusion criteria for HD were the presence of HTT gene mutation (CAG repeat number > 36). Metrics for clinical information collection include demographic data and motor function evaluated by Unified Huntington’s Disease Rating Scale-Total Motor Score (UHDRS-TMS) for HD and MDS-Unified Parkinson’s Disease Rating Scale part III (MDS-UPDRS-III) for PD; The overall function was assessed through the total functional capacity (TFC) scale for HD and the modified Hoehn-Yahr (H-Y) staging for PD. Since July 2021, NMSS was added to the enrollment protocol in these cohorts.

Results: Fifty-two HD subjects and 87 PD patients were included in this study. The age at recruitment was 48.10±11.88 years old (mean±SD) for HD and 69.22±9.93 years old (mean±SD) for PD (p<0.05). There were no significant differences in disease duration and gender distribution between HD and PD patients. The NMSS total scores in clinical HD and PD were 27.35±30.13 (mean±SD) and 36.14±30.77 (mean±SD) , respectively (p>0.05). The NMSS total scores were correlated with TFC scores (r=-0.485, p<0.01) and UHDRS-TMS scores (r=0.432, p<0.01) in HD. While in PD, the NMSS total scores were correlated with modified H-Y stage (r=0.515, p<0.001) and UPDRS-III score (r=0.430, p<0.001). The most common NMS in HD patients were easy to forget (61.5%), dysphagia (61.5.%), and constipation (44.2%), while the most common NMS in PD patients was constipation (70.1%), easy to forget (55.2%), and depression (48.3%).

Conclusion: The burdens of NMS in HD and PD are comparable; NMS are closely related to the overall function and motor function of HD and PD.

To cite this abstract in AMA style:

WZ. Hu, JH. Yin, LX. Cao, Y. Huang. A comparative study of non-motor symptoms in Huntington’s disease and Parkinson’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/a-comparative-study-of-non-motor-symptoms-in-huntingtons-disease-and-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-comparative-study-of-non-motor-symptoms-in-huntingtons-disease-and-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley